CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...
Phase 3
Budapest, Hungary and 189 other locations
female subjects who are aged 55 to 90 years and have mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis rela...
Phase 3
Budapest, Hungary and 152 other locations
psychosis associated with Alzheimer's Disease....
Phase 3
Budapest, Hungary and 208 other locations
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Budapest, Hungary and 341 other locations
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Budapest, Hungary and 381 other locations
hydrobromide \[d6-DM\]/quinidine sulfate \[Q\]) compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's...
Phase 3
Budapest, Hungary and 105 other locations
This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...
Phase 3
Budapest, Hungary and 232 other locations
Clinical trials
Research sites
Resources
Legal